VLGSX | VUSTX | VLGSX / VUSTX | |
Total Expense Ratio | 0.06 | 0.20 | 30% |
Annual Report Gross Expense Ratio | 0.06 | 0.20 | 30% |
Fund Existence | 15 years | 39 years | - |
Gain YTD | 2.300 | 0.253 | 907% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 3000 | 3000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 14.1B | 2.87B | 492% |
Annual Yield % from dividends | 4.46 | 4.20 | 106% |
Returns for 1 year | -1.88 | -5.72 | 33% |
Returns for 3 years | -9.90 | -19.08 | 52% |
Returns for 5 years | -36.23 | -49.68 | 73% |
Returns for 10 years | 1.96 | -26.52 | -7% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ARKG | 24.25 | 0.12 | +0.50% |
ARK Genomic Revolution ETF | |||
XLG | 51.20 | 0.23 | +0.45% |
Invesco S&P 500® Top 50 ETF | |||
BMN | 24.89 | N/A | +0.01% |
BlackRock 2037 Municipal Target Term Trust | |||
VXZ | 58.32 | -0.28 | -0.48% |
iPath® B S&P 500® VIX Md-Trm Futs™ ETN | |||
EIPX | 25.61 | -0.14 | -0.56% |
FT Energy Income Partners Strategy ETF |